Zixin Shi

Zixin Shi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2024 in JMIR Medical Informatics
Verified
Journal Article
Open access
ZSZixin Shi
Zixin Shi
LHLinjun Huang
Linjun Huang
XXXiaomei Xu
Xiaomei Xu
KPKexue Pu
Kexue Pu
QZQingpeng Zhang
Qingpeng Zhang
HWHaolin Wang
Haolin Wang
Background: Cirrhosis is a leading cause of non-cancer deaths in gastrointestinal diseases, resulting in high hospitalization and readmission rates. Early identification of high-risk patients is vital for proactive interventions and improve healthcare outcomes. However, the quality and integrity of real-world Electronic Health Records (EHRs) limited their utility in developing risk assessment tools. Objective: Despite the widely application of classical and ensemble machine learning for EHRs-based predictive tasks, the diversity of health conditions among patients and the inherent limitations of the data, such as incompleteness, sparsity and temporal dynamics, have not been fully addressed. To tackle those challenges, we explored a framework that characterizes patient subgroups and adaptively selects optimal predictive models for each patient on the fly to enable individualized decision support. Methods: The proposed framework uniquely addresses patient heterogeneity by aligning diverse subgroups with dynamically selected classifiers. First, patient subgroups are generated and characterized using rules indicating medical diagnosis patterns. Next, a meta-learning framework trains a meta-classifier for optimal dynamic model selection, which identifies suitable models for individual patient. Notably, we incorporated a tailored region of competence to refine model selection, specifically accounting for cirrhosis complications. This approach not only enhance predictive performance, but also elucidates why individualized predictions are better supported by selected classifiers trained on specific data subsets. Results: The proposed framework was evaluated for predicting 14-day and 30-day readmission in cirrhosis patients using multi-center data obtained from six hospitals. The final dataset comprised 3,307 patients with at least two admission records, along with a range of factors including demographic information, complications and laboratory test results. The proposed framework achieved an average AUC improvement of 5% and 4% compared to the best baseline models, respectively. Conclusions: By leveraging the expertise of the most competent classifiers for each patient subgroup, our approach enables interpretable training and dynamic selection of heterogeneous predictive models. This advancement not only improves prediction accuracy but also highlights its considerable potential for clinical applications, facilitating the alignment of diverse patient subgroups with tailored decision-support algorithms.

17 June 2026 in medRxiv
Verified
Preprint
Open access
KMKudakwashe Mukumbi
Kudakwashe Mukumbi
YLYanrong Liu
Yanrong Liu
ZSZixin Shi
Zixin Shi
ELEdward Liu
Edward Liu
ATAili Toyli
Aili Toyli
WZWeihua Zhou
Weihua Zhou
Background: The heart–brain axis links cardiovascular and neurodegenerative disease through shared vascular and inflammatory mechanisms. Although low-density lipoprotein cholesterol ( LDL-C) is an established causal factor in atherosclerotic cardiovascular disease (ASCVD), its relationship with dementia remains uncertain, with midlife elevations associated with increased risk but late-life associations often appearing null or inverse. To address this cholesterol paradox, we integrated mendelian randomization (MR) with an active-comparator new-user target trial emulation. Methods: We applied a triangulated causal inference framework integrating two-sample MR with observational target trial emulation. Genetic variants associated with LDL-C were used as instrumental variables to evaluate Alzheimer’s disease (AD), Dementia with Lewy bodies (DLB), Frontotemporal dementia (FTD), and any dementia (AnyDem), with causal estimates derived using inverse-variance weighted models and sensitivity analyses for heterogeneity and pleiotropy. In parallel, an active-comparator new-user design compared statin versus ezetimibe initiation among adults aged ≥60 years using propensity score (PS) overlap weighting and Cox proportional hazards models to evaluate cardiovascular and dementia outcomes. Results: Genetically predicted LDL-C was associated with increased risk of DLB (OR 1.65, 95% CI 1.30–2.10; p<0.001), but not AD or AnyDem; FTD estimates were inconsistent. Sensitivity analyses suggested heterogeneity and possible pleiotropy for DLB. In the observational analysis (n=6,977), statin initiation was associated with higher risks of ASCVD (HR 1.26, 95% CI 1.11–1.45) and AnyDem (HR 1.66, 95% CI 1.16–2.38), although estimates attenuated after lipid adjustment and lagged analyses, suggesting residual confounding, treatment selection, and reverse causation in late-life observational associations. Conclusions: These findings suggest that LDL-C reflects accumulated vascular and metabolic risk rather than a direct causal driver of AD or overall dementia, although a subtype-specific association was observed for DLB. Late-life associations appeared influenced by timing, reverse causation, and treatment selection, warranting cautious interpretation.

11 November 2026 in Biomedical Signal Processing and Control
Verified
Journal Article
Closed access
FTFei Tang
Fei Tang
ZSZixin Shi
Zixin Shi
NXNinglu Xu
Ninglu Xu
LHLinjun Huang
Linjun Huang
HWHaolin Wang
Haolin Wang

5 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LCLeona Chazanga
Leona Chazanga
ZSZixin Shi
Zixin Shi
RDRochak Dhakal
Rochak Dhakal
QSQiuying Sha
Qiuying Sha
Qing-Hui ChenQing-Hui Chen
Qing-Hui Chen
WZWeihua Zhou
Weihua Zhou
Cardiovascular diseases (CVD) and osteoporosis pose major clinical challenges for older adults worldwide. Evidence suggests these diseases are interconnected through shared biological mechanisms and risk factors. However, differences in the associations between specific CVD subtypes and osteoporosis remain incompletely understood. We examine osteoporosis in relation to coronary artery disease (CAD) and myocardial infarction (MI), stroke, atrial fibrillation (AF), peripheral arterial disease (PAD), and heart failure (HF). The review considers epidemiological evidence, shared biological mechanisms, medication effects, and questions for future research on cardiovascular–bone interactions. Studies addressing CVD, bone mineral density (BMD), osteoporosis, or fracture outcomes were identified through PubMed and backward citation searching.Across these cardiovascular conditions, studies report associations with low BMD, osteoporosis, or hip fracture. Their magnitude and consistency vary, however, according to the CVD subtype, study population, and skeletal outcome. Proposed links include chronic inflammation, oxidative stress, vascular calcification, endocrine dysregulation, and changes in RANK/RANKL/OPG and Wnt/β-catenin signaling. Genomic approach, large population-based cohorts, and causal inference methods offer opportunities to improve understanding of the complex cardiovascular-bone interactions. Further research is needed to classify subtype-specific associations and mechanisms, assess potential causal relationships, and determine whether these insights can improve risk prediction, prevention, early detection, and management of CVDs, osteoporosis, and osteoporotic hip fractures.